216 related articles for article (PubMed ID: 28392229)
1. Impact of intravenous contrast used in computed tomography on radiation dose to carotid arteries and thyroid in intensity-modulated radiation therapy planning for nasopharyngeal carcinoma.
Lee VHF; Ng SCY; Kwong DLW; Lam KO; Leung TW
Med Dosim; 2017 Summer; 42(2):137-144. PubMed ID: 28392229
[TBL] [Abstract][Full Text] [Related]
2. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
3. Influence of CT contrast agent on dose calculation of intensity modulated radiation therapy plan for nasopharyngeal carcinoma.
Lee FK; Chan CC; Law CK
J Med Imaging Radiat Oncol; 2009 Feb; 53(1):114-8. PubMed ID: 19453537
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
5. Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Lu J; Ma Y; Chen J; Wang L; Zhang G; Zhao M; Yin Y
J Radiat Res; 2014 Jan; 55(1):97-104. PubMed ID: 23728319
[TBL] [Abstract][Full Text] [Related]
6. Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity-modulated radiation therapy for nasopharyngeal carcinoma.
Peng YL; Chen L; Shen GZ; Li YN; Yao JJ; Xiao WW; Yang L; Zhou S; Li JX; Cheng WQ; Guan Y; Xia HQ; Liu S; Zhao C; Deng XW
Oral Oncol; 2018 Jul; 82():1-7. PubMed ID: 29909882
[TBL] [Abstract][Full Text] [Related]
7. Automatic segmentation for adaptive planning in nasopharyngeal carcinoma IMRT: Time, geometrical, and dosimetric analysis.
Fung NTC; Hung WM; Sze CK; Lee MCH; Ng WT
Med Dosim; 2020 Spring; 45(1):60-65. PubMed ID: 31345672
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of using intravenous contrast-enhanced computed tomography (CT) scans in lung cancer treatment planning.
Xiao J; Zhang H; Gong Y; Fu Y; Tang B; Wang S; Jiang Q; Li P
Radiother Oncol; 2010 Jul; 96(1):73-7. PubMed ID: 20347496
[TBL] [Abstract][Full Text] [Related]
9. Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy?
Chen C; Fei Z; Chen L; Bai P; Lin X; Pan J
Med Dosim; 2014; 39(1):34-7. PubMed ID: 24140235
[TBL] [Abstract][Full Text] [Related]
10. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.
Huang H; Lu H; Feng G; Jiang H; Chen J; Cheng J; Pang Q; Lu Z; Gu J; Peng L; Deng S; Mo Y; Wu D; Wei Y
Radiat Oncol; 2015 Sep; 10():192. PubMed ID: 26377685
[TBL] [Abstract][Full Text] [Related]
11. The impact of positron emission tomography on primary tumour delineation and dosimetric outcome in intensity modulated radiotherapy of early T-stage nasopharyngeal carcinoma.
Wu VW; Leung WS; Wong KL; Chan YK; Law WL; Leung WK; Yu YL
Radiat Oncol; 2016 Aug; 11(1):109. PubMed ID: 27558690
[TBL] [Abstract][Full Text] [Related]
12. Effect of CT contrast on volumetric arc therapy planning (RapidArc and helical tomotherapy) for head and neck cancer.
Liu AJ; Vora N; Suh S; Liu A; Schultheiss TE; Wong JY
Med Dosim; 2015; 40(1):32-6. PubMed ID: 25242679
[TBL] [Abstract][Full Text] [Related]
13. [18F]fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer.
Yasuda K; Onimaru R; Okamoto S; Shiga T; Katoh N; Tsuchiya K; Suzuki R; Takeuchi W; Kuge Y; Tamaki N; Shirato H
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):142-7. PubMed ID: 22583608
[TBL] [Abstract][Full Text] [Related]
14. Helical tomotherapy of nasopharyngeal carcinoma-any advantages over conventional intensity-modulated radiotherapy?
Wu WC; Mui WL; Fung WK
Med Dosim; 2010; 35(2):122-7. PubMed ID: 19931024
[TBL] [Abstract][Full Text] [Related]
15. [Design planning target volumes (PTVs) in intensity-modulated radiotherapy for nasopharyngeal carcinoma].
Lin CG; Li GW; Lin LW; Wu YQ; Xiao DY; Zhao C; Lu TX; Cui NJ
Ai Zheng; 2007 Feb; 26(2):200-3. PubMed ID: 17298753
[TBL] [Abstract][Full Text] [Related]
16. Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?
Chen C; Lin X; Pan J; Fei Z; Chen L; Bai P
Jpn J Radiol; 2013 Sep; 31(9):593-9. PubMed ID: 23749480
[TBL] [Abstract][Full Text] [Related]
17. Comparison of CT images with average intensity projection, free breathing, and mid-ventilation for dose calculation in lung cancer.
Khamfongkhruea C; Thongsawad S; Tannanonta C; Chamchod S
J Appl Clin Med Phys; 2017 Mar; 18(2):26-36. PubMed ID: 28300381
[TBL] [Abstract][Full Text] [Related]
18. Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Hong YS; Park S; Ahn K; Cho H
Radiother Oncol; 2006 Nov; 81(2):158-62. PubMed ID: 17050020
[TBL] [Abstract][Full Text] [Related]
19. Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer.
Chen SW; Yang SN; Liang JA; Shiau AC; Lin FJ
Med Dosim; 2005; 30(4):219-27. PubMed ID: 16275564
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma.
Lee TF; Fang FM; Chao PJ; Su TJ; Wang LK; Leung SW
Radiother Oncol; 2008 Oct; 89(1):89-96. PubMed ID: 18524401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
